(Total Views: 467)
Posted On: 07/26/2020 10:22:31 AM
Post# of 4861
Bulls Take Charge of Univec Conglomerate Inc. (OTCMKTS: UNVC)
BY JUSTIN KINNEY ON JULY 25, 2020MEDIA & TECHNOLOGY, MICRO CAP INSIDER, SMALL CAPS
Univec Conglomerate Inc. (OTCMKTS: UNVC) is one penny stock that has been rising steadily for years never giving back its gains and always moving on to new highs. From a start point in low triple zeros UNVC has skyrocketed over the years to recent highs of $0.0395. The stock has continued higher thanks to a low float and a tightly held stock structure.
The stock has attracted legions of shareholders over the years which bring in $30k to $50k a day in liquidity on a consistent basis. UNVC is led by Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry, and he has assembled an impressive BOD including John C. Peoples, Past Vice President of Merck and Kennneth Grant past Vice President of Johns Hopkins Health System.
Univec Conglomerate Inc. (OTCMKTS: UNVC) formerly Univec, Inc. (Univec), is an integrated licensing, manufacturing, and marketing company operating two divisions dedicated to providing safer health products to patients and caregivers worldwide. The Company’s syringe division develops, licenses and markets auto-disable and safety syringes worldwide. The Company is led by mover and shaker; Dr. Dalton, an inductee of three Halls of Fame, received recognition from several presidents of the United States, and is a recipient of the Senatorial-Medal of Freedom. Univec CEO Dr. David Dalton posted on linkedin “Univec Transdermal CBD Patch will have patient assistance programs including no cost.”
Last year Univec entered into a partnership with Agrimed to manufacture and distribute its medical cannabis transdermal patch for treatment and relief of approved medical conditions. A transdermal patch adheres or sticks to the skin and delivers a specific dose of medication through the skin and into the bloodstream. Agrimed is a Delaware Company developing, producing and selling products derived from cannabis. Agrimed owns one of the twelve licenses authorized by the Commonwealth of Pennsylvania to grow and process medical cannabis. Agrimed has teamed up with Former Pittsburgh Steelers great Jack Ham, a native of Johnstown, to promote the use of medical marijuana in Pennsylvania.
The Company is led by Dr David Dalton; a visionary who was named as one of the “Top 100 Healthcare Leaders” for 2019 by the International Forum on Advancements in Healthcare. With 45 years’ experience in the pharmaceutical world, Dr. Dalton served over 18 years as Vice President of Rite Aid, and then founded and served as Chairman, President, CEO of several successful pharmaceutical and pharmaceutical related companies including Mednet, ManagedcareRx, and Sivault Systems. Dr. Dalton is an inductee of three Halls of Fame, has received recognition from several presidents of the United States, and is a recipient of the Senatorial-Medal of Freedom.
Dr. Dalton received a Doctor of Pharmacy from West Virginia University School of Pharmacy. In addition to his extensive background in pharmaceutical field, he is a visiting professor and lectures at several schools of pharmacy throughout the United States, and former President of West Virginia University School of Pharmacy Presidential Committee. Dr Dalton has built an impressive BOD for UNVC including John C. Peoples, Past Vice President of Merck as well as Kenneth Grant past Vice President of Johns Hopkins Health System.
To Find out the inside Scoop on UNVC Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
#UNVC
Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005 reporting at the time: “UNIVEC, Inc. (OTCMKTS: UNVC) has been running up the charts in recent months from a start point in triple zero land to recent highs of $0.0076. The stock quickly attracted a large shareholder base which has been bidding this one higher. Currently trading at a $7.5 million market valuation according to OTCMarketsgroup it looks as if there is a lot going on behind the scenes at Univec. CEO Dr. Dalton has been very active getting elected to the board of Agrimed several days ago. He has also been busy on Linkedin recent posting “Univec Transdermal CBD Patch will have patient assistance programs including no cost.”
The Company is currently waiting on Medicare Certification. Application was made weeks ago and the only change requested by Medicare was a change in the way the company name was listed on the forms.
Currently moving steadily higher it looks as if there is a lot going on behind the scenes at Univec. UNVC is led by Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry and he has assembled an impressive BOD including John C. Peoples, Past Vice President of Merck and Kennneth Grant past Vice President of Johns Hopkins Health System. The Company is currently waiting on Medicare Certification. Application was made weeks ago and the only change requested by Medicare was a change in the way the company name was listed on the forms according to Dr. Dalton who stated on linkedin: “Univec Transdermal CBD Patch will have patient assistance programs including no cost.” Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005. We will be updating on UNVC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with UNVC.
BY JUSTIN KINNEY ON JULY 25, 2020MEDIA & TECHNOLOGY, MICRO CAP INSIDER, SMALL CAPS
Univec Conglomerate Inc. (OTCMKTS: UNVC) is one penny stock that has been rising steadily for years never giving back its gains and always moving on to new highs. From a start point in low triple zeros UNVC has skyrocketed over the years to recent highs of $0.0395. The stock has continued higher thanks to a low float and a tightly held stock structure.
The stock has attracted legions of shareholders over the years which bring in $30k to $50k a day in liquidity on a consistent basis. UNVC is led by Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry, and he has assembled an impressive BOD including John C. Peoples, Past Vice President of Merck and Kennneth Grant past Vice President of Johns Hopkins Health System.
Univec Conglomerate Inc. (OTCMKTS: UNVC) formerly Univec, Inc. (Univec), is an integrated licensing, manufacturing, and marketing company operating two divisions dedicated to providing safer health products to patients and caregivers worldwide. The Company’s syringe division develops, licenses and markets auto-disable and safety syringes worldwide. The Company is led by mover and shaker; Dr. Dalton, an inductee of three Halls of Fame, received recognition from several presidents of the United States, and is a recipient of the Senatorial-Medal of Freedom. Univec CEO Dr. David Dalton posted on linkedin “Univec Transdermal CBD Patch will have patient assistance programs including no cost.”
Last year Univec entered into a partnership with Agrimed to manufacture and distribute its medical cannabis transdermal patch for treatment and relief of approved medical conditions. A transdermal patch adheres or sticks to the skin and delivers a specific dose of medication through the skin and into the bloodstream. Agrimed is a Delaware Company developing, producing and selling products derived from cannabis. Agrimed owns one of the twelve licenses authorized by the Commonwealth of Pennsylvania to grow and process medical cannabis. Agrimed has teamed up with Former Pittsburgh Steelers great Jack Ham, a native of Johnstown, to promote the use of medical marijuana in Pennsylvania.
The Company is led by Dr David Dalton; a visionary who was named as one of the “Top 100 Healthcare Leaders” for 2019 by the International Forum on Advancements in Healthcare. With 45 years’ experience in the pharmaceutical world, Dr. Dalton served over 18 years as Vice President of Rite Aid, and then founded and served as Chairman, President, CEO of several successful pharmaceutical and pharmaceutical related companies including Mednet, ManagedcareRx, and Sivault Systems. Dr. Dalton is an inductee of three Halls of Fame, has received recognition from several presidents of the United States, and is a recipient of the Senatorial-Medal of Freedom.
Dr. Dalton received a Doctor of Pharmacy from West Virginia University School of Pharmacy. In addition to his extensive background in pharmaceutical field, he is a visiting professor and lectures at several schools of pharmacy throughout the United States, and former President of West Virginia University School of Pharmacy Presidential Committee. Dr Dalton has built an impressive BOD for UNVC including John C. Peoples, Past Vice President of Merck as well as Kenneth Grant past Vice President of Johns Hopkins Health System.
To Find out the inside Scoop on UNVC Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
#UNVC
Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005 reporting at the time: “UNIVEC, Inc. (OTCMKTS: UNVC) has been running up the charts in recent months from a start point in triple zero land to recent highs of $0.0076. The stock quickly attracted a large shareholder base which has been bidding this one higher. Currently trading at a $7.5 million market valuation according to OTCMarketsgroup it looks as if there is a lot going on behind the scenes at Univec. CEO Dr. Dalton has been very active getting elected to the board of Agrimed several days ago. He has also been busy on Linkedin recent posting “Univec Transdermal CBD Patch will have patient assistance programs including no cost.”
The Company is currently waiting on Medicare Certification. Application was made weeks ago and the only change requested by Medicare was a change in the way the company name was listed on the forms.
Currently moving steadily higher it looks as if there is a lot going on behind the scenes at Univec. UNVC is led by Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry and he has assembled an impressive BOD including John C. Peoples, Past Vice President of Merck and Kennneth Grant past Vice President of Johns Hopkins Health System. The Company is currently waiting on Medicare Certification. Application was made weeks ago and the only change requested by Medicare was a change in the way the company name was listed on the forms according to Dr. Dalton who stated on linkedin: “Univec Transdermal CBD Patch will have patient assistance programs including no cost.” Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005. We will be updating on UNVC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with UNVC.
(1)
(0)Scroll down for more posts ▼
